ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

Venous Thromboembolism » Antiphospholipid Syndrome

Theme Navigation

  • ISTH 2021 Congress
    • Venous Thromboembolism
      • Antiphospholipid Syndrome

Abstract Number: PB1057

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

C. Farkh1, S. Ellouze1, L. Gounelle1, M. Sad-Houari1, J. Duchemin1, V. Proulle1, M. Fontenay1,2, X. Delavenne3,4, G. Jourdi1,5,6,7

Abstract Number: PB1055

A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis

N. Pozzi1, V. Pengo2

Abstract Number: PB1068

A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus

I. Krichen1, S. Samet1, F. Megdich1, M. Hsairi2, L. Gargouri2, A. Mahfoudh2, C. Kallel1

Abstract Number: PB1054

Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation

R. de Laat-Kremers1, D. Wahl2, S. Zuily2, M. Ninivaggi1, W. Chayoua1, V. Regnault2, J. Musial3, P. de Groot1, K. Devreese4, B. de Laat1

Abstract Number: PB1064

Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities

Z. Cao1, R. Bottenus1, C. Kung1

Abstract Number: OC 44.1

Clinical Characteristics and Prognosis of Antiphospholipid Syndrome Patients Based on Cluster Analysis: A 10-year Cohort Study

W. Qi1, J. Zhao1,2, X. Tian1,2, M. Li1,2, X. Zeng1,2

Abstract Number: PB1051

Clinical Course of Thrombotic Antiphospholipid Syndrome with Positive IgA Anticardiolipin or IgA β2-glycoprotein I

L. Figueiredo1, B. Mazetto2, A.P. dos Santos2, B. Jacintho2, C. Vaz2, J.D. Oliveira3, G. Mesquita2, J. Annichino-Bizzachi2, F. Orsi2

Abstract Number: PB1063

Clinico-pathologic Characterization of Patients Tested for Antiphospholipid Syndrome at a Tertiary Care Hospital

K. Sajeeve1, D. K.V1, V. V1, A. Catherine Jacob1, D. Sidharth1, D. Vidyadharan1

Abstract Number: PB1050

Could the Adjusted Version of the Global Antiphospholipid Syndrome Score (aGAPSS) Be a Useful Tool to Select Patients with Primary Obstetric Antiphospholipid Syndrome (POAPS) for Primary Thromboprophylaxis with Aspirin?

S. Udry1, F. Aranda1, S. Perés Wingeyer1, S. Stephanie Morales Perez2, C. Belizna3, J. Alijotas-Reig4, E. Esteve-Valverde2, D.S. Fernández Romero5, J.O. Latino5, G. de Larrañaga1

Abstract Number: PB1053

Effect of Hydroxychloroquine on the Levels of Inflammatory Cytokines and Tissue Factor in Patients with Primary Antiphospholipid Syndrome

B. Mazetto1, S. Saraiva2, B. Jacintho2, G. Vieira-Damiani3,1, C. Vaz2, J.D. Oliveira2, A.P. dos Santos4, G. Mesquita4, J. Annichino-Bizzacchi2,5, F. Orsi5,6

Abstract Number: PB1059

Evaluation of a Gene Signature Related to Thrombotic Manifestations in Antifospholipid Syndrome

B. Jacintho1, B. Mazetto2, B. Hounkpe3, A.P. Santos4, C. Vaz1, G. Vechiatto4, J. Oliveira1, E. de Paula5,2, F. Orsi5,6

Abstract Number: PB1066

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban at Lupus Anticoagulans Positive Patients

L. Slavik1, J. Jacova2, D. Friedecky2, J. Ulehlova1, P. Bradacova1, A. Skoumalova3, J. Prochazkova1, A. Hlusi1, M. Palova1, A. Kvasnička2, E. Ivanovova2, B. Pisklakova2

Abstract Number: PB1067

Laboratory Testing Platform Discrepancy between Current Singleplex-assay and New Multiplex-assay for Detecting and Quantifying IgM-anti-Cardiolipin-antibodies and other Anti-Phospholipid (APL)-antibodies: The Potential for Mis-diagnosis of the APL-syndrome

M. Escobar1, T.E. Howard2, N. Montanez1

Abstract Number: OC 44.4

Origin of Antiphospholipid Antibodies in Autoimmunity and Viral Infection

N. Müller-Calleja1, A. Hollerbach1, N. Lemmermann2, W. Ruf3, K. Lackner1

Abstract Number: PB1061

Plasmocytoid Dendritic Cells Activity in Asymptomatic Antiphospholipid Carriers and in Primary and Secondary Antiphospholipid Syndrome with Thrombosis

A.P. Rosa dos Santos1, B. Cardoso Jacintho2, C. de Oliveira Vaz2, G. Lisiane Tripiquia Vechiatto Mesquita1, J.D. Oliveira2, J. Annichino-Bizzacchi3, S. Appenzeller4, B. Moraes Mazetto5, F. A. Orsi6

Abstract Number: PB1060

Platelet Activity from Antiphospholipid Syndrome (APS) Patients is Enhanced: Possible Role of the ADP Signaling Pathway

G. Leonardi1, C.H. Lescano1, A.P.R. Dos Santos2, B.C. Jacinto2, B.M. Mazetto2, F.A. Orsi3,4, F.Z. Mónica1

Abstract Number: OC 44.2

Predictors of Lupus Anticoagulant Test Variability over Time and its Associations with Future Thrombotic Events: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

M. Colling1,2, F. Posch1,3, S. Koder1, C. Ay1, I. Pabinger1, J. Gebhart1

Abstract Number: OC 44.3

Progression of Ischaemic and Haemorrhagic Brain Lesions on MRI in APS Patients on Antithrombotic Therapy

M. Efthymiou1,2, P. SvrKova3,4,2, R. Moll1,2, S. Nallamilli1,2, A.R. Alexandre5,6, D. Isenberg6,2, D. Werring3,4,2, R.H Jager3,4,2, H. Cohen1,2

Abstract Number: PO164

Real World Experience Use of DOAC in APLS Patients

Y.Y. Yap1, R.b. Ramli1, J. Suriar2, J. Sathar1

Abstract Number: PB1052

Risk Factors for Recurrent Thrombosis and Cause of Death in Patients with Antiphospholipid Syndrome; A Swedish Cohort Study

N. Karandyszowska1, H. Alagündüz1, J. Oesman1, M. Magnusson2, E. Svenungsson3, A. Antovic3, M. Bruzelius1

  • 1
  • 2
  • Next Page »

« View all themes from the ISTH 2021 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley